Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
Texas Instruments Plans Richardson Facility
Dallas-based Texas Instruments (TI) is planning to construct its next major semiconductor manufacturing plant in Richardson, Texas. TI will invest approximately $3 billion in the 300mm silicon wafer plant in the years following groundbreaking in late 2005. The plant will employ up to 1,000 people when fully operational. The siting of the plant in Texas will provide over $300-million in new funding from private and public sources for the Erik Jonsson School of Engineering and Computer Science at the University of Texas at Dallas.
Biosite Plans Mira Mesa Headquarters
San Diego-based Biosite is planning to construct a four-building, 350,000-sf corporate headquarters on 17.7 acres recently purchased in Mira Mesa, Calif. Biosite, a maker of rapid diagnostic products, plans to purchase an additional 8.4 acres by year-end 2003. The land, which can accommodate up to 800,000 sf, is in the 130.9 acre Fenton Technology Park. Biosite will relocate in the fourth quarter of 2004 from its nine Sorento Valley buildings where it occupies 190,000 sf. The company plans to expand its employee base from its current 700 up to 1,000 with occupancy of the new headquarters.
Neoteris Expands with Sunnyvale Relocation
Internet software maker Neoteris is relocating its headquarters from Mountain View to Sunnyvale, Calif. The new 44,702-sf facility triples Neoteris’ office space and expands available lab space for research and product development.
E-Loan Consolidates in Pleasanton
Online lender E-Loan will consolidate its 750-employee work force in 118,000-sf of the Pleasanton Corporate Commons in Pleasanton, Calif. E-Loan has an option to lease an additional 90,000-sf in the building where it will occupy four floors. The facility was one of three built for Charles Schwab Corp.
VaxGen Opens South San Francisco Facility
Brisbane, Calif.-based VaxGen has opened an $11-million facility in South San Francisco that will manufacture the company’s anthrax vaccine, AIDS vaccine, and products ranging from smallpox vaccine to monoclonal antibodies. The 17,000-sf facility is adjacent to the company’s research and development operations, and features stainless steel bioprocessors and purifiers. The facility can be easily reconfigured as manufacturing requirements change as much of the equipment is on wheels.